ReviewWorld journal of hepatology2023

Galectin-3 inhibition as a potential therapeutic target in non-alcoholic steatohepatitis liver fibrosis.

Michael KramPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.